Congfen Li
Impact in
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Viral-associated cancers and disorders 2
- Colorectal Cancer Treatments and Studies 1
-
- T-cell and B-cell Immunology 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Malcolm K. Brenner (3 shared papers)Catherine Y. Ng (3 shared papers)Helen Elisabeth Heslop (3 shared papers)Cliona M. Rooney (3 shared papers)Susan K. Loftin (2 shared papers)Robert Allen Krance (1 shared paper)Shri N. Giri (2 shared papers)Qingjian Wang (1 shared paper)
- Journals
- Nature Medicine (2 papers)Molecular Cancer Therapeutics (2 papers)Biochemical Pharmacology (1 paper)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Congfen Li
16 papers receiving 1.8k citations
Congfen Li's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 793
- Genetics 221
- Immunology 461
- Virology 45
- Hematology 132
Countries citing papers authored by Congfen Li
This map shows the geographic impact of Congfen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congfen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congfen Li more than expected).
Fields of papers citing papers by Congfen Li
This network shows the impact of papers produced by Congfen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congfen Li. The network helps show where Congfen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Congfen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes Hit paper breakdown → | 1996 | 705 |
| 2 | 2020 | 346 | |
| 3 | 2015 | 240 | |
| 4 | CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy Hit paper breakdown → | 2023 | 151 |
| 5 | 1995 | 110 | |
| 6 | 1991 | 80 | |
| 7 | 2012 | 72 | |
| 8 | 2004 | 36 | |
| 9 | 2008 | 33 | |
| 10 | 2013 | 22 | |
| 11 | 1996 | 21 | |
| 12 | 1993 | 8 | |
| 13 | 2013 | 8 | |
| 14 | 1999 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2000 | 1 |
About Congfen Li
Congfen Li is a scholar working on Oncology, Immunology, Hematology, Immunology and Allergy and Small Animals, having authored 16 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), T-cell and B-cell Immunology (2 papers), Immunotherapy and Immune Responses (2 papers), Viral-associated cancers and disorders (2 papers), Signaling Pathways in Disease (1 paper), Lung Cancer Treatments and Mutations (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Helminth infection and control (1 paper). The work is most often cited by research in Oncology (793 citations), Genetics (221 citations), Immunology (461 citations), Virology (45 citations) and Hematology (132 citations). Congfen Li has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Malcolm K. Brenner, Catherine Y. Ng, Helen Elisabeth Heslop, Cliona M. Rooney, Susan K. Loftin, Robert Allen Krance, Shri N. Giri, Qingjian Wang, Dallas M. Hyde and Priti S. Hegde. Their work appears in journals such as Nature Medicine, Molecular Cancer Therapeutics, Biochemical Pharmacology, Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.